Company Filing History:
Years Active: 2017-2018
Title: Innovations by Peter Bruin: Pioneering Biodegradable Drug-Depot Systems
Introduction
Peter Bruin, an accomplished inventor based in Groningen, Netherlands, has significantly contributed to the field of drug delivery systems. With a total of two patented innovations, Bruin is dedicated to developing biodegradable compositions that offer solutions for controlled release of pharmaceuticals.
Latest Patents
Bruin’s latest patents revolve around biodegradable compositions suitable for controlled release. These include a specialized class of drug-depot forming triblock copolymers that are particularly effective in loading, containing, and releasing sensitive drugs, such as proteins, from biodegradable and injectable drug depots. His innovative formulations utilize a tri-block copolymer structure represented as A-B-A, where A signifies a linear poly-(ethylene glycol) block and B represents a poly(lactide-co-ε-caprolactone) block. Bruin’s work also emphasizes the importance of visualizing these depots for various imaging-related purposes, further enhancing the effectiveness of these drug delivery systems.
Additionally, he has developed a composition involving the simple mixing of drug-depot forming tri-block copolymers. This innovative approach allows for cost-effective tailoring of drug delivery performances, making it applicable in both clinical and industrial settings. His work intricately describes a mixture comprising a preferred pharmaceutically active ingredient, a solvent, and various tri-block copolymer types, highlighting their modification degrees to optimize drug delivery.
Career Highlights
Peter Bruin currently works with Ingell Technologies Holding B.V., where he continues to push the boundaries of research and innovation in drug delivery systems. His unique approach has positioned him as a key player in the industry, utilizing his expertise in polymer chemistry and pharmaceutical applications to create impactful solutions.
Collaborations
In his professional journey, Bruin collaborates with dedicated colleagues such as Audrey Petit and Mike De Leeuw. Together, they strive to advance the capabilities of biodegradable drug delivery systems, pooling their knowledge and skills to foster groundbreaking innovations.
Conclusion
Peter Bruin is a notable inventor whose contributions to biodegradable compositions and drug-depot formulations are poised to revolutionize pharmaceuticals distribution. As the need for effective drug delivery solutions continues to grow, Bruin's work in this domain is essential, paving the way for future innovations in the healthcare industry. His patents reflect not only technical expertise but also a commitment to enhancing patient care through innovative technologies.